title: OKT3 and hepatitis C: defining the risks.
authors.forename: H R
authors.initials: HR
authors.lastname: Rosen
authors.forename: P
authors.initials: P
authors.lastname: Martin
mesh_terms: D006526:Hepatitis C / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation / Q000009:adverse effects*; D016853:Muromonab-CD3 / Q000009:adverse effects*; D012008:Recurrence
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3